Literature DB >> 7664024

Effects of topical antiinflammatory agents on Freund's adjuvant-induced skin lesions in rats.

G J Gendimenico1, J A Mezick.   

Abstract

Freund's adjuvant, when administered intradermally to rats, causes polyarthritis as well as inflammation of the skin, eye, gastrointestinal and genitourinary tracts. We assessed the effects of antiinflammatory drugs on ear skin lesions to determine if this might be a useful skin inflammation model. The hind paw of male Lewis rats was injected with Mycobacterium butyricum in paraffin oil. Lesions appeared between days 13 and 15 after adjuvant injection. Each ear exhibited on average 1 to 3 highly erythematous, elevated lesions, 2 to 3 mm in diameter. By histology, the lesions consisted of epidermal hyperplasia, with a prominent accumulation of inflammatory cells in the dermis. Ears were treated topically with glucocorticoids, cyclosporine and indomethacin on days 15 through 21 after adjuvant injection. By day 22, dexamethasone, fluocinolone acetonide, and cyclosporine caused near-complete clearing of lesions whereas indomethacin exacerbated the inflammation by causing increased numbers of skin lesions. These results show the potential usefulness of adjuvant-induced skin lesions in rats as a novel subchronic inflammation model.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664024     DOI: 10.1007/bf01630481

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  17 in total

Review 1.  Immunological mechanisms involved in psoriasis.

Authors:  C E Griffiths; J J Voorhees
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Topical ciclosporin for psoriasis: in vitro skin penetration and clinical study.

Authors:  R C Hermann; R S Taylor; C N Ellis; N A Williams; N D Weiner; G L Flynn; T M Annesley; J J Voorhees
Journal:  Skin Pharmacol       Date:  1988

3.  Effects of cyclooxygenase and lipoxygenase inhibitors on inflammation associated with oxazolone-induced delayed hypersensitivity.

Authors:  R Meurer; E E Opas; J L Humes
Journal:  Biochem Pharmacol       Date:  1988-09-15       Impact factor: 5.858

4.  Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents.

Authors:  L M De Young; J B Kheifets; S J Ballaron; J M Young
Journal:  Agents Actions       Date:  1989-03

5.  Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate.

Authors:  P L Stanley; S Steiner; M Havens; K M Tramposch
Journal:  Skin Pharmacol       Date:  1991

6.  Low-dose cyclosporin A in severe psoriasis. A double-blind study.

Authors:  T Van Joost; J D Bos; F Heule; M M Meinardi
Journal:  Br J Dermatol       Date:  1988-02       Impact factor: 9.302

7.  Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes. Comparison of the experimental process with human disease.

Authors:  C M PEARSON; B H WAKSMAN; J T SHARP
Journal:  J Exp Med       Date:  1961-03-01       Impact factor: 14.307

Review 8.  Atopic dermatitis: recent trends in pathogenesis and therapy.

Authors:  K D Cooper
Journal:  J Invest Dermatol       Date:  1994-01       Impact factor: 8.551

9.  Pharmacological modification of 12-0-tetradecanoylphorbol-13-acetate induced inflammation and epidermal cell proliferation in mouse skin.

Authors:  R J Griffiths; B E Wood; S Li; A Blackham
Journal:  Agents Actions       Date:  1988-12

10.  Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.

Authors:  R P Carlson; L O'Neill-Davis; J Chang; A J Lewis
Journal:  Agents Actions       Date:  1985-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.